Synonyms: compound 12 [Fraser et al., 2016] [1] | eCF-309
Compound class:
Synthetic organic
Comment: eCF309 is a low nanomolar potency, selective and cell-permeable mTOR inhibitor [1].
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Bioactivity Comments |
eCF309 is active in in vitro enzyme assays and acts as a potent cell cycle inhibitor in cell assays [1]. In a kinase screening panel 10 μM eCF309 inhibited mTOR by 99%. The only other wild type kinases inhibited by >60% were DNA-PK (90%), PI3Kγ (85%), and DDR1 (77%). |
Selectivity at enzymes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|